top of page
Image by Sweet Life

GLP-1 Content

Glucagon-like peptide-1 receptor agonists (GLP-1s), like Ozempic, are medications originally developed to manage diabetes. In the last few years, they gained popularity for treating obesity. 

With their growing popularity, there is a great demand for information on this class of medications. The ongoing research on the GLP-1s means more information is available all of the time.

 

My experience as a nurse practitioner informs my writing with the knowledge of how the medications work, an ability to understand the new research, and the patient's viewpoint on obesity and obesity-related issues. All of this means I can translate complex information into the content readers are looking for with these treatments.

Content Topics

  • LinkedIn
bottom of page